{"brief_title": "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)", "brief_summary": "The purpose of this study is to assess the safety and efficacy of 2 doses of an approved drug for a new indication in the prevention of postoperative nausea and vomiting in patients receiving general anesthesia for open abdominal surgery requiring overnight hospital stay.", "detailed_description": "The duration of treatment is 4 weeks.", "condition": ["Postoperative Nausea and Vomiting"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0869, aprepitant", "Comparator: ondansetron IV"], "criteria": "Inclusion Criteria: - Patient is at least 18 years of age. - Patient is scheduled to undergo open abdominal surgery requiring overnight hospital stay (24-hour hospital stay after end of surgery). - Patient is scheduled to receive general anesthesia. - Patient is scheduled to receive postoperative medication.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Nausea", "Vomiting", "Postoperative Nausea and Vomiting", "Aprepitant", "Fosaprepitant", "Ondansetron"], "id": "NCT00090155"}